Greenwich LifeSciences, Inc. (GLSI)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $20.58
- As of
Kresmion compiles this page from GLSI's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Greenwich LifeSciences, Inc. (GLSI): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-16.
See the full GLSI dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for GLSI on one page. Preview it with sample data, then open it live with a free account.
Preview the GLSI dossierActive events for GLSI
- mediumEarnings above estimates
Q2-2026: Beat consensus by 19.8%, EPS $-0.27 vs $-0.3366 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 77.7% - EPS $-0.58 vs $-0.3264 estimate
- mediumEarnings below estimates
Q1-2026: Missed consensus by 15.9% - EPS $-0.39 vs $-0.3366 estimate
- mediumEarnings below estimates
Q4-2024: Missed consensus by 184.8% - EPS $-0.61 vs $-0.2142 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 22.5% - EPS $-0.3 vs $-0.2448 estimate
FREE, NO ACCOUNT
Every event on GLSI, as it fires
New filings, 13F moves and cross asset events on GLSI land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, GLSI
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
Going concern statement
GLSI's 10-Q filed Nov 16, 2026 states:
These circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on GLSI
GLSI against its peers
GLSI's return on equity of -5480.5% ranks in the 2nd percentile of 21 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | GLSI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | n/a | 14.2M | n/a | 16 |
| Operating margin | n/a | -340.4% | n/a | 15 |
| Net margin | n/a | -436.5% | n/a | 15 |
| Return on equity | -5480.5% | -67.4% | 2 | 21 |
| 1 year | 130.0% | -25.7% | 94 | 23 |
Peers (23): PROK, IKT, ACIU, LCTX, FTH, LXEO, BCYC, NGEN, CAMP, PALI, IMRX, ARCT, VNDA, TRDA, PRQR, CGEN, ARTV, QTTB, RNAC, PYXS, RCKT, PLX, KRRO. Left out: DRUG (period gap), HSTC (period gap). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (GLSI: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in GLSI on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on GLSI in the last 180 days.
Upstream: SEC EDGAR filings for GLSI
Kresmion, "Greenwich LifeSciences, Inc. (GLSI) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/GLSI. Upstream data: SEC EDGAR filings for GLSI.
Link to this data (HTML):
<a href="https://kresmion.com/research/GLSI">Greenwich LifeSciences, Inc. (GLSI) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow GLSI on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to GLSI for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.